Martina Molsbergen,
C14 CEO, has more than 25 years of business development, marketing and entrepreneurial experience – including more than fifteen years of business development expertise in cutting edge technology tools and products for biotherapeutics, immunotherapies and regenerative medicine., She has mentored and catapulted several cutting-edge platform technologies and products to commercial success. With her strong abilities in business development networking, she has helped to launch several start-up companies into the global biotech and pharma arena. And she has proven corporate development strategy and leadership experience within large and small company settings.
YOUR PREMIER BUSINESS DEVELOPMENT SOURCE FOR
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $210 | 104.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 64 | 38848316 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 18281126 | 25 |
View Market Depth
| Last trade - 12.28pm 27/06/2025 (20 minute delay) ? |
| BIT (ASX) Chart |